C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease

American Journal of Cardiology

Volumn 88, Issue 10, 2001, Pages 1139-1142

  Madsen, Trine ^a,d   Skou, Helle Aarup ^b   Hansen, Vibeke Ellegaard ^b   Fog, Lars ^a   Christensen, Jeppe Hagstrup ^a   Toft, Egon ^c   Schmidt, Erik Berg ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b NORTH DENMARK REGIONAL HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; FISH; FOOD INTAKE; GRANULOCYTE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR;

ADULT; AGED; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; DIET; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035889484     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02049-5     Document Type: Article

References (25)

1. Atherosclerosis - An inflammatory disease
2. Molecular bases of the acute coronary syndromes
3. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
4. Production of C-reactive protein and risk of coronary events in stable and unstable angina
5. Long-term effects of pravastatin on plasma concentration of C-reactive protein
6. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease
7. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
8. n-3 fatty acids and the risk of coronary heart disease
9. Dietary polyunsaturated fatty acids and inflammatory mediator production
10. Lipid mediators in inflammatory disorders
11. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography
12. n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men
13. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
14. Inflammatory markers in men with angiographically documented coronary heart disease
15. C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes
16. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs
17. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells
18. Fatty acid modulation of endothelial activation
19. Dietary n-3 fatty acids and therapy for rheumatoid arthritis
20. Lipid treatment of inflammatory bowel disease
21. Heart rate variability and fatty acid content of blood cell membranes: A dose-response study with n-3 fatty acids
22. Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: Study design implications
23. Essential fatty acids in health and chronic disease
24. n-3 fatty acids and leucocytes
25. n-3 fatty acids and acute-phase proteins